Table 1 Characteristics of patients with versus without cancer at one year
From: Predictive score for estimating cancer after venous thromboembolism: a cohort study
Cancer1(N=32) | No cancer (N=317) | p value | |
|---|---|---|---|
Demographic factor | |||
Age, median (IQR), y | 71 (57–81) | 73 (57–81) | 0.81 |
Male sex N (%) | 18 (56) | 125 (39) | 0.08 |
Hospitalized at time of diagnosis N (%) | 11 (34) | 121 (38) | 0.71 |
Main diagnosis | |||
DVT diagnosis N (%) | 21 (66) | 240 (76) | 0.21 |
PE diagnosis N (%) | 14 (44) | 128 (40) | 0.71 |
VTE risk factors | |||
Major surgery N (%) | 5 (16) | 114 (36) | 0.02 |
Previous VTE N (%) | 7 (22) | 1 (0.3) | <0.001 |
Family history of VTE N (%) | 2 (6.2) | 9 (2.8) | 0.29 |
Trauma N (%) | 1 (3) | 46 (14) | 0.08 |
Oral contraceptives N (%) | 0 (0) | 13 (4.1) | 0.24 |
Recent travel N (%) | 7 (21) | 19 (6) | <0.001 |
Inmovility N (%) | 8 (25) | 127 (40) | 0.09 |
Comorbidities | |||
Charlson score, median (IQR) | 3 (0.5-4.5) | 1(0–2) | <0.001 |
Physical examination | |||
BMI, mean (SD), kg/m2 | 26.4 (5) | 27.7 (5) | 0.24 |
Laboratory findings | |||
Albumin levels, median (IQR), mg/dl | 3 (IR 2–3.6) | 3 (IR 2.6-3.6) | 0.61 |
Hemoglobin, mean (SD), mg/dl | 11.3 (IR 2) | 11.7 (IR 2) | 0.29 |
Death within one year N (%) | 23 (72%) | 60 (19%) | <0.001 |